All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The development of personalized neoantigen peptide vaccines will specifically and effectively target cancer cells in individuals, opening a new door for cancer immunotherapy. Creative Biolabs has cGMP-certified production facilities and expertise that enable us to produce non-GMP and GMP grade peptides. Using state-of-the-art equipment and an experienced team with the latest technology, Creative Biolabs' comprehensive range of high-quality peptide synthesis services includes customized peptide synthesis, high-throughput peptide libraries, and peptide array services.
Creative Biolabs' GMP manufacturing facilities are designed in strict accordance with the FDA's GMP manufacturing guidelines. We produce peptides up to 50 amino acids in length ranging from grams to kilograms. Our manufacturing capabilities are designed to meet the needs of our customers:
For more details, please feel free to contact us for project quotations and more detailed information.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION